$TECH
BIO-TECHNE Corp Stock $tech

$tech Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-K Financial Statement

#000155837023015226 Filed on August 23, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2023
Revenue	$276.9M	$301.3M	$1.137B
YoY Change	2.7%	4.54%	2.81%
Cost Of Revenue	$91.74M	$96.62M	$366.9M
YoY Change	1.87%	9.95%	5.09%
Gross Profit	$185.2M	$204.7M	$769.8M
YoY Change	3.12%	2.17%	1.76%
Gross Profit Margin	66.87%	67.93%	67.72%
Selling, General & Admin	$105.3M	$86.35M	$378.4M
YoY Change	5.99%	-10.31%	1.51%
% of Gross Profit	56.88%	42.19%	49.15%
Research & Development	$24.00M	$23.42M	$92.49M
YoY Change	0.4%	1.17%	6.14%
% of Gross Profit	12.96%	11.44%	12.01%
Depreciation & Amortization	$28.54M	$26.92M	$107.2M
YoY Change	7.13%	4.09%	6.1%
% of Gross Profit	15.41%	13.15%	13.93%
Operating Expenses	$129.3M	$109.8M	$470.9M
YoY Change	4.91%	-8.08%	2.38%
Operating Profit	$55.86M	$94.93M	$298.9M
YoY Change	-0.81%	17.3%	0.79%
Interest Expense	$4.893M	-$2.667M	$11.22M
YoY Change	29.1%	-1.84%	-0.83%
% of Operating Profit	8.76%	-2.81%	3.75%
Other Income/Expense, Net	-$6.304M	-$3.542M	$39.72M
YoY Change	-113.3%	-396.15%	728.09%
Pretax Income	$49.56M	$88.32M	$338.7M
YoY Change	-52.22%	11.72%	12.37%
Income Tax	-$1.435M	$12.83M	$53.22M
% Of Pretax Income	-2.9%	14.53%	15.71%
Net Earnings	$50.99M	$75.47M	$285.3M
YoY Change	-43.06%	22.66%	4.86%
Net Earnings / Revenue	18.41%	25.05%	25.1%
Basic Earnings Per Share	$0.32		$1.81
Diluted Earnings Per Share	$0.31	$0.47	$1.76
COMMON SHARES
Basic Shares Outstanding	158.2M	157.4M	157.2M
Diluted Shares Outstanding	161.9M		161.9M

Balance Sheet

Concept	2023 Q3	2023 Q2	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$148.7M	$204.3M	$204.3M
YoY Change	-26.78%	-17.29%	-17.29%
Cash & Equivalents	$148.7M	$180.6M	$180.6M
Short-Term Investments	$0.00	$23.74M	$23.74M
Other Short-Term Assets	$52.16M	$27.07M	$27.07M
YoY Change	110.57%	18.42%	18.42%
Inventory	$186.1M	$171.6M	$171.6M
Prepaid Expenses
Receivables	$204.6M	$218.5M	$218.5M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$591.5M	$621.5M	$621.5M
YoY Change	7.15%	2.63%	2.63%
LONG-TERM ASSETS
Property, Plant & Equipment	$231.7M	$226.2M	$324.5M
YoY Change	3.38%	1.33%	12.37%
Goodwill	$969.4M	$872.7M
YoY Change	12.01%	6.16%
Intangibles	$579.0M	$534.6M
YoY Change	-1.12%	0.59%
Long-Term Investments	$251.6M	$255.9M
YoY Change		923.43%
Other Assets	$281.6M	$285.3M	$285.3M
YoY Change	422.45%	509.26%	509.26%
Total Long-Term Assets	$2.164B	$2.017B	$2.017B
YoY Change	20.3%	19.41%	19.41%
TOTAL ASSETS
Total Short-Term Assets	$591.5M	$621.5M	$621.5M
Total Long-Term Assets	$2.164B	$2.017B	$2.017B
Total Assets	$2.755B	$2.639B	$2.639B
YoY Change	17.21%	14.99%	14.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$28.08M	$25.68M	$77.31M
YoY Change	-7.85%	-24.17%	128.28%
Accrued Expenses	$15.94M	$14.88M	$11.20M
YoY Change	15.57%	-16.81%	-87.8%
Deferred Revenue	$24.52M	$23.07M
YoY Change	11.14%	-1.44%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Short-Term Liabilities	$127.8M	$128.5M	$128.5M
YoY Change	-7.18%	-26.99%	-26.99%
LONG-TERM LIABILITIES
Long-Term Debt	$440.0M	$350.0M	$350.0M
YoY Change	66.25%	43.79%	43.79%
Other Long-Term Liabilities	$9.394M	$10.92M	$104.7M
YoY Change	-18.32%	-10.79%	38.89%
Total Long-Term Liabilities	$9.394M	$10.92M	$454.7M
YoY Change	-18.32%	-10.79%	42.63%
TOTAL LIABILITIES
Total Short-Term Liabilities	$127.8M	$128.5M	$128.5M
Total Long-Term Liabilities	$9.394M	$10.92M	$454.7M
Total Liabilities	$137.1M	$139.4M	$672.2M
YoY Change	-8.03%	-25.94%	13.35%
SHAREHOLDERS EQUITY
Retained Earnings	$1.328B	$1.309B
YoY Change	14.2%	16.61%
Common Stock	$748.2M	$723.1M
YoY Change	9.96%	10.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.998B	$1.967B	$1.967B
YoY Change
Total Liabilities & Shareholders Equity	$2.755B	$2.639B	$2.639B
YoY Change	17.21%	14.99%	14.99%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2023
OPERATING ACTIVITIES
Net Income	$50.99M	$75.47M	$285.3M
YoY Change	-43.06%	22.66%	4.86%
Depreciation, Depletion And Amortization	$28.54M	$26.92M	$107.2M
YoY Change	7.13%	4.09%	6.1%
Cash From Operating Activities	$59.38M	$83.39M	$254.4M
YoY Change	5.89%	-18.81%	-21.79%
INVESTING ACTIVITIES
Capital Expenditures	$13.59M	$10.83M	$38.24M
YoY Change	42.24%	-179.82%	-14.84%
Acquisitions	$166.4M		$101.2M
YoY Change	64.48%
Other Investing Activities	-$140.5M	$6.075M	-$227.4M
YoY Change	1286.7%	-221.5%	337.8%
Cash From Investing Activities	-$154.1M	-$4.756M	-$265.6M
YoY Change	682.76%	-74.39%	174.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$10.25M
YoY Change			-93.63%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	71.51M	-24.22M	22.62M
YoY Change	-324.84%	-63.15%	-109.31%
NET CHANGE
Cash From Operating Activities	59.38M	83.39M	254.4M
Cash From Investing Activities	-154.1M	-4.756M	-265.6M
Cash From Financing Activities	71.51M	-24.22M	22.62M
Net Change In Cash	-31.91M	54.41M	11.36M
YoY Change	336.5%	195.43%	-142.83%
FREE CASH FLOW
Cash From Operating Activities	$59.38M	$83.39M	$254.4M
Capital Expenditures	$13.59M	$10.83M	$38.24M
Free Cash Flow	$45.79M	$72.56M	$216.1M
YoY Change	-1.58%	-37.6%	-22.9%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000842023
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2022Q2	tech	Undesignated Capital Stock Shares Outstanding UndesignatedCapitalStockSharesOutstanding	0
CY2023Q2	tech	Undesignated Capital Stock Shares Outstanding UndesignatedCapitalStockSharesOutstanding	0
CY2023Q2	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023	dei	Entity Registrant Name EntityRegistrantName	BIO-TECHNE Corp
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	156644212
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	157641914
CY2022	us-gaap	Impairment Of Intangible Asset Indefinite Lived Excluding Goodwill Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpense
CY2022Q2	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	0-17272
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MN
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-1427402
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	614 McKinley Place N.E.
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Minneapolis
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55413
CY2023	dei	City Area Code CityAreaCode	612
CY2023	dei	Local Phone Number LocalPhoneNumber	379-8854
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2023	dei	Trading Symbol TradingSymbol	TECH
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022Q4	dei	Entity Public Float EntityPublicFloat	13000000000.0
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	158174312
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1136702000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1105599000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	931032000
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	366887000
CY2022	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	87140000
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	349103000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	298182000
CY2023	us-gaap	Gross Profit GrossProfit	769815000
CY2022	us-gaap	Gross Profit GrossProfit	756496000
CY2021	us-gaap	Gross Profit GrossProfit	632850000
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	378378000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	372766000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	324951000
CY2023	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	92493000
CY2021	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	70603000
CY2023	us-gaap	Operating Expenses OperatingExpenses	470871000
CY2022	us-gaap	Operating Expenses OperatingExpenses	459906000
CY2021	us-gaap	Operating Expenses OperatingExpenses	395554000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	298944000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	296590000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	237296000
CY2023	us-gaap	Interest Expense InterestExpense	11215000
CY2022	us-gaap	Interest Expense InterestExpense	11309000
CY2021	us-gaap	Interest Expense InterestExpense	13952000
CY2023	us-gaap	Investment Income Net InvestmentIncomeNet	3410000
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	794000
CY2021	us-gaap	Investment Income Net InvestmentIncomeNet	473000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	47520000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	15311000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-75642000
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	39715000
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4796000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-89121000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	338659000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	301386000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	148175000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	53217000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	38287000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8590000
CY2023	us-gaap	Profit Loss ProfitLoss	285442000
CY2022	us-gaap	Profit Loss ProfitLoss	263099000
CY2021	us-gaap	Profit Loss ProfitLoss	139585000
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	179000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-8952000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-825000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	285263000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	272051000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	140410000
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	4191000
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-32241000
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	32951000
CY2023	tech	Other Comprehensive Income Loss Release Of Foreign Currency Transaction And Translation From Sale Portion Attributable To Parent OtherComprehensiveIncomeLossReleaseOfForeignCurrencyTransactionAndTranslationFromSalePortionAttributableToParent	119000
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	4793000
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	14262000
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	7060000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	9103000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-17979000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	40011000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-33000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-70000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	103000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	9136000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-17909000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	39908000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	294399000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	254142000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	180318000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.81
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.73
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.91
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.76
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.66
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.87
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	157179000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	156874000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	154986000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	161855000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	164114000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	161932000
CY2022Q4	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	4
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	180571000
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	172567000
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	23739000
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	74462000
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4738000
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2568000
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	218468000
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	194548000
CY2023Q2	us-gaap	Inventory Net InventoryNet	171638000
CY2022Q2	us-gaap	Inventory Net InventoryNet	141123000
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	27066000
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	22856000
CY2023Q2	us-gaap	Assets Current AssetsCurrent	621482000
CY2022Q2	us-gaap	Assets Current AssetsCurrent	605556000
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	226200000
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	223242000
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	98326000
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	65556000
CY2023Q2	us-gaap	Goodwill Goodwill	872737000
CY2022Q2	us-gaap	Goodwill Goodwill	822101000
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	534645000
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	531522000
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	285302000
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	46828000
CY2023Q2	us-gaap	Assets Assets	2638692000
CY2022Q2	us-gaap	Assets Assets	2294805000
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	25679000
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	33865000
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	36747000
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	61953000
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	14880000
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17886000
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	23069000
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	23406000
CY2023Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	12022000
CY2022Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	13237000
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11199000
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11928000
CY2023Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	3500000
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	12500000
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1413000
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1243000
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	128509000
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	176018000
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	88982000
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	98994000
CY2023Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	350000000
CY2022Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	243410000
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	5000000
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	93766000
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	58133000
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10919000
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	12239000
CY2022Q2	tech	Undesignated Capital Stock No Par Value UndesignatedCapitalStockNoParValue	0
CY2023Q2	tech	Undesignated Capital Stock No Par Value UndesignatedCapitalStockNoParValue	0
CY2022Q2	tech	Undesignated Capital Stock Shares Authorized UndesignatedCapitalStockSharesAuthorized	5000000
CY2023Q2	tech	Undesignated Capital Stock Shares Authorized UndesignatedCapitalStockSharesAuthorized	5000000
CY2022Q2	tech	Undesignated Capital Stock Shares Issued UndesignatedCapitalStockSharesIssued	0
CY2023Q2	tech	Undesignated Capital Stock Shares Issued UndesignatedCapitalStockSharesIssued	0
CY2023Q2	tech	Undesignated Capital Stock Value UndesignatedCapitalStockValue	0
CY2022Q2	tech	Undesignated Capital Stock Value UndesignatedCapitalStockValue	0
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	157641914
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	156644212
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	1576000
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	1566000
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	721543000
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	652467000
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1309461000
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1122937000
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-66064000
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-75200000
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1966516000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1701770000
CY2022Q2	us-gaap	Minority Interest MinorityInterest	-759000
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1966516000
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1701011000
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2638692000
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2294805000
CY2022Q4	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	4
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1381192000
CY2021	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	8985000
CY2021	us-gaap	Profit Loss ProfitLoss	139585000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	40011000
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	43178000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	49821000
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-7057000
CY2021	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	49622000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	48065000
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2791000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	917000
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1571234000
CY2022	us-gaap	Profit Loss ProfitLoss	263099000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-17979000
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	160950000
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	60895000
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-9978000
CY2022	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	50185000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	41208000
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2694000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	973000
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1701011000
CY2023	tech	Other Comprehensive Income Loss Release Of Foreign Currency Transaction And Translation From Sale Portion Attributable To Parent OtherComprehensiveIncomeLossReleaseOfForeignCurrencyTransactionAndTranslationFromSalePortionAttributableToParent	119000
CY2023	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	613000
CY2023	us-gaap	Profit Loss ProfitLoss	285442000
CY2023	tech	Other Comprehensive Income Loss Before Translation Reclassification Net Of Tax OtherComprehensiveIncomeLossBeforeTranslationReclassificationNetOfTax	8984000
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	19562000
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2789000
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-6731000
CY2023	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	50285000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	38315000
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	4906000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	915000
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1966516000
CY2022Q4	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	4
CY2023	us-gaap	Profit Loss ProfitLoss	285442000
CY2022	us-gaap	Profit Loss ProfitLoss	263099000
CY2021	us-gaap	Profit Loss ProfitLoss	139585000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	107238000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	101069000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	87747000
CY2023	tech	Fair Value Write Up Of Acquired Inventory FairValueWriteUpOfAcquiredInventory	400000
CY2022	tech	Fair Value Write Up Of Acquired Inventory FairValueWriteUpOfAcquiredInventory	1596000
CY2021	tech	Fair Value Write Up Of Acquired Inventory FairValueWriteUpOfAcquiredInventory	1565000
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-29567000
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	6816000
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-27431000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	39230000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	42183000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	48982000
CY2023	tech	Fair Value Adjustment To Contingent Consideration Payable FairValueAdjustmentToContingentConsiderationPayable	-12100000
CY2022	tech	Fair Value Adjustment To Contingent Consideration Payable FairValueAdjustmentToContingentConsiderationPayable	-20400000
CY2021	tech	Fair Value Adjustment To Contingent Consideration Payable FairValueAdjustmentToContingentConsiderationPayable	5300000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-3300000
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-337000
CY2023	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	37176000
CY2023	tech	Fair Value Adjustment On Available For Sale Securities FairValueAdjustmentOnAvailableForSaleSecurities	-472000
CY2022	tech	Fair Value Adjustment On Available For Sale Securities FairValueAdjustmentOnAvailableForSaleSecurities	-15002000
CY2021	tech	Fair Value Adjustment On Available For Sale Securities FairValueAdjustmentOnAvailableForSaleSecurities	67879000
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1143000
CY2022	tech	Asset Impairment Restructuring Charge AssetImpairmentRestructuringCharge	546000
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	18715000
CY2023	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee	11682000
CY2023	tech	Noncash Portion Of Lease Expense NoncashPortionOfLeaseExpense	2059000
CY2022	tech	Noncash Portion Of Lease Expense NoncashPortionOfLeaseExpense	-1201000
CY2021	tech	Noncash Portion Of Lease Expense NoncashPortionOfLeaseExpense	75000
CY2023	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	455000
CY2022	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	668000
CY2021	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-464000
CY2023	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	20867000
CY2022	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	57596000
CY2021	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	15549000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	30167000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	32007000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7140000
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	4585000
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	3082000
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1101000
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-7908000
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	12741000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	19091000
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-24558000
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	7760000
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	20536000
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-2492000
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	2667000
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	13426000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	254393000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	325272000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	352164000
CY2023	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	35236000
CY2022	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	26055000
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	66377000
CY2023	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	20500000
CY2022	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	52998000
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	39684000
CY2023	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	73219000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	38244000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	44908000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	44301000
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	101184000
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	225352000
CY2021	tech	Investment In Unconsolidated Entity InvestmentInUnconsolidatedEntity	556000
CY2023	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	17824000
CY2022	us-gaap	Payments For Derivative Instrument Investing Activities PaymentsForDerivativeInstrumentInvestingActivities	25000000
CY2023	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	232000000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-265649000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-96851000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-243516000
CY2023	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	50285000
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	50185000
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	49622000
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	29813000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	77155000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	65092000
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	19562000
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	160950000
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	43178000
CY2023	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	619661000
CY2022	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	90000000
CY2021	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	256000000
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	525661000
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	175500000
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	271500000
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	700000
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	28893000
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	23461000
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	19343000
CY2023	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-2457000
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	788000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	22616000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-242853000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-62551000
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-3356000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-12092000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6369000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8004000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-26524000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	52466000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	172567000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	199091000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	146625000
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	180571000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	172567000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	199091000
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2022Q4	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	4
CY2022Q4	us-gaap	Stock Issued During Period Shares Stock Splits StockIssuedDuringPeriodSharesStockSplits	3
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;"><i style="font-style:italic;">Use of estimates:</i> The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. These estimates include the valuation of accounts receivable, available-for-sale investments, inventory, intangible assets, contingent consideration, stock-based compensation and income taxes. Actual results could differ from these estimates.</p>
CY2023	us-gaap	Advertising Expense AdvertisingExpense	4800000
CY2022	us-gaap	Advertising Expense AdvertisingExpense	4600000
CY2021	us-gaap	Advertising Expense AdvertisingExpense	4700000
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	459912000
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	434665000
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	233712000
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	211423000
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2021	us-gaap	Number Of Reporting Units NumberOfReportingUnits	5
CY2022	us-gaap	Number Of Reporting Units NumberOfReportingUnits	5
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	5
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	5
CY2022	us-gaap	Number Of Reporting Units NumberOfReportingUnits	5
CY2023Q2	us-gaap	Restructuring Reserve RestructuringReserve	0
CY2021	tech	Proceeds From Laboratory Services Reimbursed By Medicare ProceedsFromLaboratoryServicesReimbursedByMedicare	500000
CY2023	tech	Proceeds For Non Medicare Laboratory Services ProceedsForNonMedicareLaboratoryServices	900000
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	24600000
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	25500000
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	21500000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1136702000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1105599000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	931032000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1136702000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1105599000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	931032000
CY2023Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	84551000
CY2022Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	79291000
CY2023Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	92474000
CY2022Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	66943000
CY2023Q2	tech	Inventory Net Current And Non Current InventoryNetCurrentAndNonCurrent	177025000
CY2022Q2	tech	Inventory Net Current And Non Current InventoryNetCurrentAndNonCurrent	146234000
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	226200000
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	223242000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	992515000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	923996000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	480570000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	415174000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	511945000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	508822000
CY2023Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	22700000
CY2022Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	22700000
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	534645000
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	531522000
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	531522000
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	615968000
CY2023	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	75600000
CY2023	tech	Finitelived Intangible Assets Other Additions FinitelivedIntangibleAssetsOtherAdditions	5710000
CY2022	tech	Finitelived Intangible Assets Other Additions FinitelivedIntangibleAssetsOtherAdditions	293000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	77491000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	74147000
CY2023	us-gaap	Finite Lived Intangible Assets Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss	696000
CY2022	us-gaap	Finite Lived Intangible Assets Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss	2029000
CY2022	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	8563000
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	534645000
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	531522000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	75331000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	72056000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	68089000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	57920000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	54470000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	184079000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	511945000
CY2021Q2	us-gaap	Goodwill Goodwill	843067000
CY2022	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-4407000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	8275000
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-8284000
CY2022Q2	us-gaap	Goodwill Goodwill	822101000
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	51257000
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-621000
CY2023Q2	us-gaap	Goodwill Goodwill	872737000
CY2023Q2	us-gaap	Equity Method Investments EquityMethodInvestments	255857000
CY2022Q2	us-gaap	Equity Method Investments EquityMethodInvestments	25000000
CY2023Q2	us-gaap	Derivative Assets DerivativeAssets	16857000
CY2022Q2	us-gaap	Derivative Assets DerivativeAssets	11026000
CY2023Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	5387000
CY2022Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	5111000
CY2023Q2	tech	Assets Classified As Noncurrent Other AssetsClassifiedAsNoncurrentOther	7201000
CY2022Q2	tech	Assets Classified As Noncurrent Other AssetsClassifiedAsNoncurrentOther	5691000
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	285302000
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	46828000
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	88428000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	30341000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	20952000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	8368000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	11027000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	13576000
CY2023	tech	Acquisition Related Liabilities AcquisitionRelatedLiabilities	12100000
CY2022	tech	Acquisition Related Liabilities AcquisitionRelatedLiabilities	20400000
CY2021	tech	Acquisition Related Liabilities AcquisitionRelatedLiabilities	23600000
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	4000000
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	4400000
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	15900000
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.32
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.32
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.32
CY2023	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	222000
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	98326000
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11199000
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	93766000
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	104965000
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y3M29D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0427
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	14934000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	48103000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	15167000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	14957000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	15097000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	12484000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	12482000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	59715000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	129902000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	24937000
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	104965000
CY2023	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	88.12
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1576952
CY2022	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	102.06
CY2021	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	480000
CY2021	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	89.95
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	28900000
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	23500000
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	19300000
CY2023	us-gaap	Profit Loss ProfitLoss	285442000
CY2022	us-gaap	Profit Loss ProfitLoss	263099000
CY2021	us-gaap	Profit Loss ProfitLoss	139585000
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	179000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-8952000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-825000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	285263000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	272051000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	140410000
CY2023	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	70000
CY2022	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	121000
CY2021	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	86000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	285193000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	271930000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	140324000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	157179000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	156874000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	154986000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.81
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.73
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.91
CY2023	us-gaap	Profit Loss ProfitLoss	285442000
CY2022	us-gaap	Profit Loss ProfitLoss	263099000
CY2021	us-gaap	Profit Loss ProfitLoss	139585000
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	179000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-8952000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-825000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	285263000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	272051000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	140410000
CY2023	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	70000
CY2022	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	121000
CY2021	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	86000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	285193000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	271930000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	140324000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	157179000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	156874000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	154986000
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4676000
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	7240000
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	6946000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	161855000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	164114000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	161932000
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.76
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.66
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.87
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4500000
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2800000
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2400000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0034
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0027
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0047
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.30
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.36
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.27
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.33
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.25
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.30
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.028
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.044
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.006
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.026
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.002
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.007
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y8M12D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y3M18D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y4M24D
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14435000
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	35.07
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3051000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	69.44
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	109000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	53.58
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2509000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	28.13
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14868000
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	43.16
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1390000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	120.15
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	539000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	87.05
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2450000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	33.61
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13269000
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	51.20
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2351000
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	93.81
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	118000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	85.99
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1578000
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	29.48
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13924000
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	60.56
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	843300000
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y4M24D
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	7057000
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	31.61
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	7797000
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	36.99
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	8641000
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	44.76
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	386700000
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y4M24D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	29.53
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	29.78
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	14.94
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	90200000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	209300000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	145600000
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	46500000
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	82300000
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	70500000
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	27400000
CY2023	tech	Share Based Compensation Arrangement By Share Based Payment Award Nonvested Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedForfeitureRate	0.045
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y2M12D
CY2023	us-gaap	Interest Expense InterestExpense	11215000
CY2022	us-gaap	Interest Expense InterestExpense	11309000
CY2021	us-gaap	Interest Expense InterestExpense	13952000
CY2023	us-gaap	Investment Income Net InvestmentIncomeNet	3410000
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	794000
CY2021	us-gaap	Investment Income Net InvestmentIncomeNet	473000
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	49328000
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	15186000
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	-68047000
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1143000
CY2023	tech	Other Nonoperating Income And Expense OtherNonoperatingIncomeAndExpense	-665000
CY2022	tech	Other Nonoperating Income And Expense OtherNonoperatingIncomeAndExpense	125000
CY2021	tech	Other Nonoperating Income And Expense OtherNonoperatingIncomeAndExpense	-7595000
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	39715000
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4796000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-89121000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	288458000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	255118000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	95662000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	50201000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	46268000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	52513000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	338659000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	301386000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	148175000
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	59810000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	10080000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	15179000
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	12753000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	6663000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	6681000
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	10453000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	14481000
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	14743000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	83016000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	31224000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	36603000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-28829000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	8130000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-20812000
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2414000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1477000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-4962000
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	1444000
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-2544000
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-2239000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-29799000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7063000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-28013000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	53217000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	38287000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8590000
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.157
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.127
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.127
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.058
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	29300000
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	12300000
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	29300000
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	28100000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.025
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.022
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.006
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.013
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.010
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.018
CY2023	tech	Effective Income Tax Rate Reconciliation Contingent Consideration Adjustment EffectiveIncomeTaxRateReconciliationContingentConsiderationAdjustment	-0.008
CY2022	tech	Effective Income Tax Rate Reconciliation Contingent Consideration Adjustment EffectiveIncomeTaxRateReconciliationContingentConsiderationAdjustment	-0.014
CY2021	tech	Effective Income Tax Rate Reconciliation Contingent Consideration Adjustment EffectiveIncomeTaxRateReconciliationContingentConsiderationAdjustment	0.008
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.006
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.004
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.008
CY2023	tech	Effective Income Tax Rate Reconciliation Gains Losses On Investments EffectiveIncomeTaxRateReconciliationGainsLossesOnInvestments	-0.007
CY2022	tech	Effective Income Tax Rate Reconciliation Gains Losses On Investments EffectiveIncomeTaxRateReconciliationGainsLossesOnInvestments	0.011
CY2023	tech	Effective Income Tax Rate Reconciliation Option Exercises EffectiveIncomeTaxRateReconciliationOptionExercises	-0.033
CY2022	tech	Effective Income Tax Rate Reconciliation Option Exercises EffectiveIncomeTaxRateReconciliationOptionExercises	-0.094
CY2021	tech	Effective Income Tax Rate Reconciliation Option Exercises EffectiveIncomeTaxRateReconciliationOptionExercises	-0.169
CY2023	tech	Effective Income Tax Rate Reconciliation Foreign Earnings Taxation EffectiveIncomeTaxRateReconciliationForeignEarningsTaxation	0.004
CY2022	tech	Effective Income Tax Rate Reconciliation Foreign Earnings Taxation EffectiveIncomeTaxRateReconciliationForeignEarningsTaxation	-0.001
CY2021	tech	Effective Income Tax Rate Reconciliation Foreign Earnings Taxation EffectiveIncomeTaxRateReconciliationForeignEarningsTaxation	-0.001
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Fdii Percent EffectiveIncomeTaxRateReconciliationFdiiPercent	0.034
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Fdii Percent EffectiveIncomeTaxRateReconciliationFdiiPercent	0.019
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Fdii Percent EffectiveIncomeTaxRateReconciliationFdiiPercent	0.051
CY2023	tech	Effective Income Tax Rate Reconciliation Foreign Withholding Tax Percent EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxPercent	0.015
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.008
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.019
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.065
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.004
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0010
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.000
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.157
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.127
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.058
CY2023Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	10906000
CY2022Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	8033000
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	20315000
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	27948000
CY2023Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	9218000
CY2022Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	13131000
CY2023Q2	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	939000
CY2022Q2	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	2435000
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	16528000
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	11778000
CY2023Q2	tech	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	21001000
CY2022Q2	tech	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	13779000
CY2023Q2	tech	Deferred Tax Assets Capitalized Research And Development Costs DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts	21081000
CY2023Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	4379000
CY2022Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	8585000
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9344000
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9466000
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	95023000
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	76223000
CY2022Q2	us-gaap	Deferred Tax Liabilities Other Comprehensive Income DeferredTaxLiabilitiesOtherComprehensiveIncome	6963000
CY2023Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	134810000
CY2022Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	133672000
CY2023Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	21449000
CY2022Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	18060000
CY2023Q2	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	20021000
CY2022Q2	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	12793000
CY2023Q2	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	3995000
CY2022Q2	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	2480000
CY2023Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	3730000
CY2022Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1249000
CY2023Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	184005000
CY2022Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	175217000
CY2023Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	88982000
CY2022Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	98994000
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9300000
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9500000
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9300000
CY2023Q2	tech	Undistributed Earnings Of Foreign Subsidiaries Permanently And Non Permanently Reinvested UndistributedEarningsOfForeignSubsidiariesPermanentlyAndNonPermanentlyReinvested	219000000
CY2023Q2	tech	Undistributed Earnings Of Foreign Subsidiaries Non Permanently Reinvested UndistributedEarningsOfForeignSubsidiariesNonPermanentlyReinvested	99000000
CY2023Q2	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	120000000
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5302000
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	7271000
CY2020Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4297000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	960000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	304000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	4038000
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	357000
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	778000
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	2860000
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	286000
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Foreign Currency Translation UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation	11000
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Foreign Currency Translation UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation	16000
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5291000
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5302000
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	7271000
CY2023Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	5300000
CY2023Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	500000
CY2022Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	300000
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1136702000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1105599000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	931032000
CY2023	tech	Fair Value Write Up Of Acquired Inventory FairValueWriteUpOfAcquiredInventory	400000
CY2022	tech	Fair Value Write Up Of Acquired Inventory FairValueWriteUpOfAcquiredInventory	1596000
CY2021	tech	Fair Value Write Up Of Acquired Inventory FairValueWriteUpOfAcquiredInventory	1565000
CY2023	tech	Amortization Of Acquired Intangible Assets AmortizationOfAcquiredIntangibleAssets	76413000
CY2022	tech	Amortization Of Acquired Intangible Assets AmortizationOfAcquiredIntangibleAssets	73054000
CY2021	tech	Amortization Of Acquired Intangible Assets AmortizationOfAcquiredIntangibleAssets	64239000
CY2023	tech	Impact Of Partially Owned Consolidated Subsidiaries ImpactOfPartiallyOwnedConsolidatedSubsidiaries	-647000
CY2022	tech	Impact Of Partially Owned Consolidated Subsidiaries ImpactOfPartiallyOwnedConsolidatedSubsidiaries	2393000
CY2021	tech	Impact Of Partially Owned Consolidated Subsidiaries ImpactOfPartiallyOwnedConsolidatedSubsidiaries	1505000
CY2023	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	-9965000
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	-19070000
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	7114000
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	18715000
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	41217000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	46401000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	51846000
CY2023	us-gaap	Restructuring Charges RestructuringCharges	3829000
CY2022	us-gaap	Restructuring Charges RestructuringCharges	1640000
CY2021	us-gaap	Restructuring Charges RestructuringCharges	142000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	298944000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	296590000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	237296000
CY2023Q2	us-gaap	Noncurrent Assets NoncurrentAssets	226200000
CY2022Q2	us-gaap	Noncurrent Assets NoncurrentAssets	223242000
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	534645000
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	531522000
CY2023	dei	Auditor Name AuditorName	KPMG LLP
CY2023	dei	Auditor Location AuditorLocation	Minneapolis, Minnesota
CY2023Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	185

Files In Submission

Name	View Source	Status
0001558370-23-015226-index-headers.html	Edgar Link	pending
0001558370-23-015226-index.html	Edgar Link	pending
0001558370-23-015226.txt	Edgar Link	pending
0001558370-23-015226-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tmb-20230630.xsd	Edgar Link	pending
tmb-20230630x10k.htm	Edgar Link	pending
tmb-20230630x10k005.jpg	Edgar Link	pending
tmb-20230630xex19.htm	Edgar Link	pending
tmb-20230630xex21d1.htm	Edgar Link	pending
tmb-20230630xex23.htm	Edgar Link	pending
tmb-20230630xex31d1.htm	Edgar Link	pending
tmb-20230630xex31d2.htm	Edgar Link	pending
tmb-20230630xex32d1.htm	Edgar Link	pending
tmb-20230630xex32d2.htm	Edgar Link	pending
tmb-20230630xex4d1.htm	Edgar Link	pending
tmb-20230630_cal.xml	Edgar Link	unprocessable
tmb-20230630_def.xml	Edgar Link	unprocessable
tmb-20230630_lab.xml	Edgar Link	unprocessable
tmb-20230630_pre.xml	Edgar Link	unprocessable
tmb-20230630x10k_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TECH
BIO-TECHNE Corp Stock $tech

2023 Q3 Form 10-K Financial Statement

#000155837023015226 Filed on August 23, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TECH BIO-TECHNE Corp Stock $tech

2023 Q3 Form 10-K Financial Statement

#000155837023015226 Filed on August 23, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TECH
BIO-TECHNE Corp Stock $tech